Efficacy and safety of the CDK4/6 inhibitor palbociclib during different lines of treatment in patients with advanced stage endocrine sensitive/HER2 negative breast cancer.
Détails
ID Serval
serval:BIB_899C43F0DBF7
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Efficacy and safety of the CDK4/6 inhibitor palbociclib during different lines of treatment in patients with advanced stage endocrine sensitive/HER2 negative breast cancer.
Périodique
Journal of Clinical Oncology
ISSN
0732-183X
1527-7755
1527-7755
Statut éditorial
Publié
Date de publication
20/05/2018
Volume
36
Numéro
15_suppl
Pages
e13052-e13052
Langue
anglais
Mots-clé
Cancer Research, Oncology
Web of science
Création de la notice
24/08/2021 11:50
Dernière modification de la notice
19/09/2021 15:55
Données d'usage
